i2O Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

i2O Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

i2O Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2019

SEC CIK1782226

What does i2O Therapeutics do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $3.5 million sold (2023).

Frequently asked questions about i2O Therapeutics

Where is i2O Therapeutics headquartered?

i2O Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does i2O Therapeutics do?

i2O Therapeutics, Inc. is a biotechnology company.

When was i2O Therapeutics founded?

The earliest incorporation on record for i2O Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences